Aotearoa New Zealand had a vaping prevalence of 1.4% in 2015/2016[xxiii] - this was in contrast to the UK, which in 2016 had a legal vape market and a vaping prevalence four times that of Aotearoa New Zealand at 5.7%.[xxiv] Following legalisation of nicotine-containing vaping products in 2018, Aotearoa New Zealand experienced a rapid uptake of vaping, to the extent that vaping product use has, as of 2022, overtaken tobacco smoking in Aotearoa New Zealand, according to the latest data from the New Zealand Health Survey.[xxv] Shortly after the legalisation of nicotine vaping products in Aotearoa New Zealand, a 2019 survey of current and former smokers in 14 countries,[xxvi] including the USA, Australia and China, found that Aotearoa New Zealand had the second highest prevalence of vaping among ex-and-current- smokers, second only to the United Kingdom
They have not built the editorial citation infrastructure to match
Disclaimer: This content is for informational purposes only and does not constitute legal advice
What to Expect During the Screening During a low-dose CT screening, you will lie flat on the exam table, with pillows and straps used for comfort and to help maintain the correct position
As your body acclimates to functioning without nicotine and other dangerous chemicals, you may experience cravings, irritability and yes, sleepless nights
On the revised website, WS-3 is not listed as an ingredient of the new varieties introduced in 2025 (Newport non-menthol Box, Newport Reserve non-menthol Box) (Figure 1F)